Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial

BACKGROUND: Young male cancer survivors have lower testosterone levels, higher fat mass, and worse quality of life (QoL) than age-matched healthy controls. Low testosterone in cancer survivors can be due to orchidectomy or effects of chemotherapy and radiotherapy. We have undertaken a double-blind,...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Jennifer S., Marshall, Helen, Smith, Isabelle L., Greenfield, Diana M., Swain, Jayne, Best, Emma, Ashton, James, Brown, Julia M., Huddart, Robert, Coleman, Robert E., Snowden, John A., Ross, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850530/
https://www.ncbi.nlm.nih.gov/pubmed/31714912
http://dx.doi.org/10.1371/journal.pmed.1002960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850530/
https://www.ncbi.nlm.nih.gov/pubmed/31714912
http://dx.doi.org/10.1371/journal.pmed.1002960

Ejemplares similares